Картка документу
ІМУНОГЕННА КОМПОЗИЦІЯ
Бібліографія
Патент України (на 20 р.)
(51)
МПК
A61K 39/085 (2006.01)
A61K 31/70 (2006.01)
A61P 31/04 (2006.01)
A61K 39/085 (2006.01)
A61K 31/70 (2006.01)
A61P 31/04 (2006.01)
(11)
97359
(22)
29.03.2007
(24)
10.02.2012
(21)
a200810922
(31)
606416.6
(32)
30.03.2006
(33)
GB
(31)
60/787,249
(32)
30.03.2006
(33)
US
(31)
60/787,587
(32)
30.03.2006
(33)
US
(41)
25.11.2008, бюл. № 22
(46)
10.02.2012, бюл. № 3
(56)
US2002031528 A1, 17.05.1998.
WO03061558 A2, 31.07.2003.
WO2005000346 A, 06.01.2005.
WO2006065553 A, 22.06.2006.
WO2006032472 A, 30.03.2006.
WO0056360 A, 28.09.2000.
FATTOM A I ET AL: "Antigenic determinants of Staphylococcus aureus type 5 and type 8 capsular polysaccharide vaccines" INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 66, no. 10, October 1998 (1998-10), pages 4588-4592.
FATTOM A I ET AL: "Development of StaphVAX
, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials" VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 22, no. 7, 17 February 2004 (2004-02-17), pages 880-887.
, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials" VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 22, no. 7, 17 February 2004 (2004-02-17), pages 880-887.MOREAU M ET AL: "STRUCTURE OF THE TYPE 5 CAPSULAR POLYSACCHARIDE OF STAPHYLOCOCCUS-AUREUS" CARBOHYDRATE RESEARCH, vol. 201, no. 2, 1990, pages 285-298.
JONES C: "Revised structures for the capsular polysaccharides from Staphylococcus aureus Types 5 and 8, components of novel glycoconjugate vaccines" CARBOHYDRATE RESEARCH, ELSEVIER SCIENTIFIC PUBLISHING COMPANY. AMSTERDAM, NL, vol. 340, no. 6, 2 May 2005 (2005-05-02), pages 1097-1106.
BHASIN NAVNEET ET AL: "Identification of a gene essential for O-acetylation of the Staphylococcus aureus type 5 capsular polysaccharide" MOLECULAR MICROBIOLOGY, vol. 27, no. 1, January 1998 (1998-01), pages 9-21.
MAIRA-LITRAN T ET AL: "COMPARATIVE OPSONIC AND PROTECTIVE ACTIVITIES OF STAPHYLOCOCCUS AUREUS CONJUGATE VACCINES CONTAINING NATIVE OR DEACETYLATED STAPHYLOCOCCAL POLY-N-ACETYL-BETA-(1-6)-GLUCOSAMINE" INFECTION AND IMMUNITY, AMERICAN SOCIETY OF MICROBIOLOGY, WASHINGTON, DC, US, vol. 73, no. 10, October 2005 (2005-10), pages 6752-6762.
MAIRA-LITRAN T ET AL: "Immunochemical Properties of the Staphylococcal Poly-N-Acetylglucosamine SurfacePolysaccharide" INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 70, no. 8, August 2002 (2002-08), pages 4433-4440.
(85)
30.10.2008
(86)
PCT/EP2007/053057, 29.03.2007
(71)
ҐЛАКСОСМІТКЛАЙН БАЙОЛОДЖІКАЛЗ С.А. 
ГЛАКСОСМИТКЛАЙН БАЙОЛОДЖИКАЛЗ С.А.
GLAXOSMITHKLINE BIOLOGICALS S.A.
(72)
Деноель Філіпп ; Полман Ян
; Полман Ян Деноэль Филипп ; Полман Ян
; Полман Ян Denoel Philippe ; Poolman Jan
; Poolman Jan (73)
ҐЛАКСОСМІТКЛАЙН БАЙОЛОДЖІКАЛЗ С.А.
ГЛАКСОСМИТКЛАЙН БАЙОЛОДЖИКАЛЗ С.А.
GLAXOSMITHKLINE BIOLOGICALS S.A.
(74)
Крилова Надія Іванівна
(98)
Крилова Надiя Iванiвна
вул. Дмитрівська, 56б, офіс 1, м. Київ, 01054
вул. Дмитрівська, 56б, офіс 1, м. Київ, 01054